What is the optimal antiplatelet therapy in patients with chronic coronary syndrome undergoing coronary artery bypass grafting?

J Cardiothorac Surg · 2026 · PMC13317372 · PMID 42092999

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendP = 0.10so close (0.05 < p ≤ 0.1)

Compared to low-dose aspirin, aspirin at higher doses showed a trend toward reduced graft failure risk (RR:0.74; 95% CI [0.52—1.06]; P = 0.10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.